Trial
NCT03307993
Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
H. Lundbeck A/S
Collaborators
—
Condition
Alzheimer's Disease
Intervention
Idalopirdine
Why stopped
The study was terminated for strategic reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-04